These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9195550)

  • 1. Characterization of surfactant subtypes of beractant and a synthetic peptide containing surfactant KL4 following surface area cycling and addition of fibrinogen.
    Manalo E; Merritt TA; Amirkhanian JD; Kheiter A
    Lung; 1997; 175(4):225-33. PubMed ID: 9195550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.
    Manalo E; Merritt TA; Kheiter A; Amirkhanian J; Cochrane C
    Pediatr Res; 1996 Jun; 39(6):947-52. PubMed ID: 8725253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative inactivation of surfactants.
    Andersson S; Kheiter A; Merritt TA
    Lung; 1999; 177(3):179-89. PubMed ID: 10192765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro conversion of surfactant subtypes is altered in alveolar surfactant isolated from injured lungs.
    Higuchi R; Lewis J; Ikegami M
    Am Rev Respir Dis; 1992 Jun; 145(6):1416-20. PubMed ID: 1596011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of modified natural surfactant after exposure to fibrinogen in vitro and in an animal model of respiratory distress syndrome.
    Calkovska A; Linderholm B; Haegerstrand-Björkman M; Curstedt T
    Pediatr Res; 2012 Sep; 72(3):262-9. PubMed ID: 22691953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant subtypes of mice: metabolic relationships and conversion in vitro.
    Gross NJ; Narine KR
    J Appl Physiol (1985); 1989 Jul; 67(1):414-21. PubMed ID: 2759970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of the surface-tension-lowering ability of surfactant after exposure to hypochlorous acid.
    Merritt TA; Amirkhanian JD; Helbock H; Halliwell B; Cross CE
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):19-22. PubMed ID: 8216215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant subtypes. In vitro conversion, in vivo function, and effects of serum proteins.
    Ueda T; Ikegami M; Jobe A
    Am J Respir Crit Care Med; 1994 May; 149(5):1254-9. PubMed ID: 8173767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein composition of synthetic surfactant affects gas exchange in surfactant-deficient rats.
    Walther FJ; Hernández-Juviel J; Bruni R; Waring AJ
    Pediatr Res; 1998 May; 43(5):666-73. PubMed ID: 9585014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro.
    Cockshutt AM; Weitz J; Possmayer F
    Biochemistry; 1990 Sep; 29(36):8424-9. PubMed ID: 2252903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies.
    Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W
    Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates.
    Veldhuizen RA; Inchley K; Hearn SA; Lewis JF; Possmayer F
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):141-7. PubMed ID: 8216208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition of biophysical surface properties and change in ultrastructures of exogenous pulmonary surfactant by albumin or fibrinogen.
    Park J; Bae CW; Choi YM
    J Korean Med Sci; 1998 Apr; 13(2):123-30. PubMed ID: 9610611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface properties, morphology and protein composition of pulmonary surfactant subtypes.
    Putman E; Creuwels LA; van Golde LM; Haagsman HP
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):599-605. PubMed ID: 8973573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of surfactant protein B from canine surfactant large aggregates during formation of small surfactant aggregates by in vitro surface area cycling.
    Inchley K; Cockshutt A; Veldhuizen R; Possmayer F
    Biochim Biophys Acta; 1999 Aug; 1440(1):49-58. PubMed ID: 10477824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant.
    Seeger W; Thede C; Günther A; Grube C
    Biochim Biophys Acta; 1991 Jan; 1081(1):45-52. PubMed ID: 1991155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of pH on surface properties of lung surfactants.
    Amirkhanian JD; Merritt TA
    Lung; 1995; 173(4):243-54. PubMed ID: 7564483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic peptide-containing surfactants--evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution.
    Nilsson G; Gustafsson M; Vandenbussche G; Veldhuizen E; Griffiths WJ; Sjövall J; Haagsman HP; Ruysschaert JM; Robertson B; Curstedt T; Johansson J
    Eur J Biochem; 1998 Jul; 255(1):116-24. PubMed ID: 9692909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan decreases surfactant inactivation in vitro.
    Lu KW; Goerke J; Clements JA; Taeusch HW
    Pediatr Res; 2005 Feb; 57(2):237-41. PubMed ID: 15585679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a cationic and hydrophobic peptide, KL4, on model lung surfactant lipid monolayers.
    Ma J; Koppenol S; Yu H; Zografi G
    Biophys J; 1998 Apr; 74(4):1899-907. PubMed ID: 9545051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.